2018 Raynauds Disease Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Raynauds Disease Market

2018 Raynauds Disease Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Raynauds Disease Market

  • June 2018 •
  • 70 pages •
  • Report ID: 5442352 •
  • Format: PDF
Raynauds Disease refers to a vascular condition that affects the blood flow to small tissues such as the ones in hands and toes. Around 20 to 25 million people are affected by Raynauds Disease in the US.
To assist researchers, investors and business development managers, VPA Research has come up with a comprehensive report on Raynauds Disease pipeline. The report provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials). Drugs under development directly and through combination with other drugs are also included.

Current status, developmental phase, participating companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Raynauds Disease pipeline product. Mechanism of Action and the target area of the pipeline product are also provided. Further, clinical and preclinical trials along with results of the trials are also included in the report.

In addition to complete details of each product, the report provides key trends in Raynauds Disease pipeline studies. The products under development are categorized according to their development phase, mechanism and company to provide detailed insights into the type of drugs being developed and the stages of development.